Pharmacologic Response and Safety of Inhaled Insulin in Type 1 Diabetes

NCT02713841 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG: inhaled human insulin (INH)
DRUG: sc insulin lispro (LIS)

Sponsor

Dance Biopharm Inc.